Biotech · Public company · Red Bank, NJ, US

Hepion Pharmaceuticals, Inc.

Ticker HEPA · SEC CIK 0001583771

Track this companyFree. Adds Hepion Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs8From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline8

CRV431 225mgPhase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
CRV431 75mgPhase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
RencofilstatPhase 2 · Nonalcoholic Steatohepatitis (NASH)ClinicalTrials.gov · fetched Nov 12, 2026
rencofilstat, 150mgPhase 2 · NASH With FibrosisClinicalTrials.gov · fetched Nov 12, 2026
rencofilstat, 225 mgPhase 2 · NASH With FibrosisClinicalTrials.gov · fetched Nov 12, 2026
rencofilstat, 75 mgPhase 2 · NASH With FibrosisClinicalTrials.gov · fetched Nov 12, 2026
CRV431Phase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
TDFPhase 1 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026

A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisPHASE2 · UNKNOWN · started Oct 15, 2022ClinicalTrials.gov NCT05402371 · fetched Nov 12, 2026
A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3PHASE2 · COMPLETED · started Mar 15, 2022ClinicalTrials.gov NCT05461105 · fetched Nov 12, 2026
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 SubjectsPHASE2 · COMPLETED · started Jun 23, 2020ClinicalTrials.gov NCT04480710 · fetched Nov 12, 2026
A Study in Healthy VolunteersPHASE1 · COMPLETED · started Jul 9, 2019ClinicalTrials.gov NCT03596697 · fetched Nov 12, 2026